Long Buildup & Trading Above the 50-DMAbullish
F&O stocks adding fresh long positions while holding above their 50-day moving average — F&O flow confirming the trend.
4 stocks · ranked by significance · click any symbol for the full smart-money deep dive · Download CSV
| Stock | LTP | Price % | OI Δ% | vs 50-DMA |
|---|---|---|---|---|
| INDIANBIndian Bank | 854.10 | +0.07% | +2.71% | +0.19% |
| BLUESTARCOBlue Star Ltd. | 1567.60 | +0.10% | +2.05% | +3.27% |
| DRREDDYDr. Reddy's Laboratories Ltd. | 1233.00 | +0.85% | +1.46% | +3.78% |
| ANGELONEAngel One Ltd. | 300.00 | +1.17% | +0.57% | +2.31% |
How this screen works
Long Buildup tells you fresh long positions are being added in F&O; trading above the 50-day moving average tells you the stock is already in a short-to-medium-term uptrend. Together they are stronger than either alone — flow and trend agreeing.
This screen intersects the two: F&O stocks classified Long Buildup today and trading above their 50-DMA, ranked by the size of the open-interest increase.
Strota takes the Long Buildup list (price up + OI up, from the F&O bhavcopy) and keeps only stocks whose latest close is above their 50-day simple moving average.
The 'vs 50-DMA' column shows how far above the average the stock is trading; 'OI Δ%' shows the strength of the fresh positioning.
This is a confluence signal — flow and trend aligned — not a recommendation. Confirm with levels and market direction.
FAQ
Why combine Long Buildup with the 50-DMA?
Long Buildup shows fresh F&O long positions; the 50-DMA shows the price trend. When both agree — new longs in an uptrend — the signal is stronger than either on its own.
Can other screeners show this?
Pure price/volume screeners can't, because they don't have F&O open-interest classification. This combination of flow plus technical is specific to Strota's data.
How often does it update?
Each session, once the F&O bhavcopy and the daily price history are processed.
Is this buy/sell advice?
No. It is a confluence signal built from public exchange data — information to research, not a recommendation.